Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GMSJ granules for treatment of influenza
CTR20192365Phase 2Terminated
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GMSJ in influenza, sponsored by Yangtze River Pharmaceutical Group. Started Dec 2019; status: terminated.
02
Drugs
GMSJ
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20192365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192365.